Other Information
−Removed: Incorporated by Reference
−Removed: Filed or Furnished Herewith
−Removed: Form of Pre-funded Warrant
−Removed: Form of Securities Purchase Agreement
−Removed: First Amendment to Collaboration, Option and License Agreement, dated August 13, 2019, by and between the Registrant and Gilead Sciences, Inc.
−Removed: Second Amendment to Collaboration, Option and License Agreement, dated September 9, 2022, by and between the Registrant and Gilead Sciences, Inc.
−Removed: Second Amendment to Collaboration and License Agreement, dated December 16, 2021, by and between the Registrant and Genzyme Corporation
−Removed: Third Amendment to Collaboration and License Agreement, dated July 7, 2022, by and between the Registrant and Genzyme Corporation
−Removed: Fourth Amendment to Collaboration and License Agreement, dated August 11, 2022, by and between the Registrant and Genzyme Corporation
+Added: Incorporated by Reference Filed or Furnished Herewith
+Added: Number Description Form File No.
+Added: Exhibit Filing Date
31.1 Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
2 unchanged sentences
Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
−Removed: Inline XBRL Instance Document - the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
−Removed: Inline XBRL Taxonomy Extension Schema Document
−Removed: Inline XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Definition Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Label Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: Cover Page Interactive Data File (formatted as Inline XBRL and included in exhibit 101)
−Removed: Registrant has omitted certain schedules pursuant to Item 601(a)(5) of Regulation S-K promulgated by the SEC.
−Removed: Registrant has omitted portions of the exhibit as permitted under Item 601(b)(10) of Regulation S-K.
−Removed: The certifications furnished in Exhibit 32.1 hereto are deemed to accompany this Quarterly Report on Form 10-Q and are not deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
+Added: 101.INS Inline XBRL Instance Document - the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document X
+Added: 101.SCH Inline XBRL Taxonomy Extension Schema Document X
+Added: 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document X
+Added: 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document X
+Added: 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document X
+Added: 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document X
+Added: 104 Cover Page Interactive Data File (formatted as Inline XBRL and included in exhibit 101) X
+Added: * The certifications furnished in Exhibits 32.1 hereto are deemed to accompany this Quarterly Report on Form 10-Q and are not deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act of the Exchange Act.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
NURIX THERAPEUTICS, INC.
−Removed: October 6, 2022
−Removed: /s/ Arthur T.
+Added: April 13, 2023
+Added: /s/ A RTHUR T.
Sands, M.D., Ph.D.
1 unchanged sentence
(Principal Executive Officer)
−Removed: October 6, 2022
−Removed: /s/ Hans van Houte
+Added: April 13, 2023
+Added: /s/ H ANS VAN H OUTE
Hans van Houte
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.